Immune Checkpoint Inhibitors and Vaccination: Assessing Safety, Efficacy, and Synergistic Potential.

导出 LinkOut

翻译打印收藏纠错

作者： Jacob,New ^[1] ; Luke,Shenton ^[2] ; Radia,Ksayer ^[3] ; Justin,Wang ^[2] ; Karam,Zakharia ^[3] ; Laura J,Nicholson ^[1] ; Amitabh C,Pandey ^[4]

作者单位： Department of Medicine, Scripps Health, La Jolla, CA 92121, USA.;Scripps Research Translational Institute, La Jolla, CA 92037, USA. ^[1] Department of Medicine, Scripps Health, La Jolla, CA 92121, USA. ^[2] Department of Medicine, Tulane University, New Orleans, LA 70112, USA. ^[3] Department of Medicine, Tulane University, New Orleans, LA 70112, USA.;Section of Cardiology, Department of Medicine, Tulane University, New Orleans, LA 70112, USA.;Southeast Louisiana Veterans Health Care System, New Orleans, LA 70112, USA. ^[4]

关键词 cancer vaccination immune checkpoint inhibitors (ICIs)immunotherapy infectious disease vaccination mRNA vaccines

DOI 10.3390/vaccines12111270

PMID 39591173

发布时间 2024-11-30

翻译满意度评价：

准确一般字义偏差语意偏离译文作用小提交

浏览0

Vaccines

2024年12卷11期

相似文献

中文期刊
外文期刊
学位论文
会议论文

检索历史清除

Immune Checkpoint Inhibitors and Vaccination: Assessing Safety, Efficacy, and Synergistic Potential.

Vaccines

相似文献

Vaccines

相关期刊

参考文献：
指定格式：	NoteExpress EndNote RefWorks NoteFirst

检索历史 清除

Immune Checkpoint Inhibitors and Vaccination: Assessing Safety, Efficacy, and Synergistic Potential.

Vaccines

相似文献

Vaccines

相关期刊

检索历史清除